Literature DB >> 29654112

Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD.

Tao Xie1, Lisa Bloom2, Mahesh Padmanaban1, Breanna Bertacchi1, Wenjun Kang3, Ellen MacCracken2, Abraham Dachman4, Julie Vigil2, David Satzer5, Cindy Zadikoff6, Katerina Markopoulou7, Peter Warnke5, Un Jung Kang8.   

Abstract

OBJECTIVE: To evaluate the long-term effect of 60 Hz stimulation of the subthalamic nucleus (STN) on dysphagia, freezing of gait (FOG) and other motor symptoms in patients with Parkinson's disease (PD) who have FOG at the usual 130 Hz stimulation.
METHODS: This is a prospective, sequence randomised, crossover, double-blind study. PD patients with medication refractory FOG at 130 Hz stimulation of the STN were randomised to the sequences of 130 Hz, 60 Hz or deep brain stimulation off to assess swallowing function (videofluoroscopic evaluation and swallowing questionnaire), FOG severity (stand-walk-sit test and FOG questionnaire) and motor function (Unified PD Rating Scale, Part III motor examination (UPDRS-III)) at initial visit (V1) and follow-up visit (V2, after being on 60 Hz stimulation for an average of 14.5 months), in their usual medications on state. The frequency of aspiration events, perceived swallowing difficulty and FOG severity at 60 Hz compared with 130 Hz stimulation at V2, and their corresponding changes at V2 compared with V1 at 60 Hz were set as primary outcomes, with similar comparisons in UPDRS-III and its subscores as secondary outcomes.
RESULTS: All 11 enrolled participants completed V1 and 10 completed V2. We found the benefits of 60 Hz stimulation compared with 130 Hz in reducing aspiration frequency, perceived swallowing difficulty, FOG severity, bradykinesia and overall axial and motor symptoms at V1 and persistent benefits on all of them except dysphagia at V2, with overall decreasing efficacy when comparing V2 to V1.
CONCLUSIONS: The 60 Hz stimulation, when compared with 130 Hz, has long-term benefits on reducing FOG, bradykinesia and overall axial and motor symptoms except dysphagia, although the overall benefits decrease with long-term use. CLINICAL TRIAL REGISTRATION: NCT02549859; Pre-results. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  DBS; Parkinson’s disease; STN; dysphagia; freezing; frequency; gait

Mesh:

Year:  2018        PMID: 29654112     DOI: 10.1136/jnnp-2018-318060

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

Review 1.  The Effect of Deep Brain Stimulation on Swallowing Function in Parkinson's Disease: A Narrative Review.

Authors:  Min Cheol Chang; Jin-Sung Park; Byung Joo Lee; Donghwi Park
Journal:  Dysphagia       Date:  2021-01-02       Impact factor: 3.438

2.  STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson's disease.

Authors:  Francesco Bove; Danilo Genovese; Martina Petracca; Tommaso Tufo; Danila Pisani; Maria Rita Lo Monaco; Anna Rita Bentivoglio; Paolo Calabresi; Carla Piano
Journal:  NPJ Parkinsons Dis       Date:  2022-06-29

Review 3.  Freezing of gait in Parkinson's disease: pathophysiology, risk factors and treatments.

Authors:  Chao Gao; Jun Liu; Yuyan Tan; Shengdi Chen
Journal:  Transl Neurodegener       Date:  2020-04-15       Impact factor: 8.014

4.  Frequency-dependent effects of subthalamic deep brain stimulation on motor symptoms in Parkinson's disease: a meta-analysis of controlled trials.

Authors:  Dongning Su; Huimin Chen; Wanli Hu; Yuye Liu; Zhan Wang; Xuemei Wang; Genliang Liu; Huizi Ma; Junhong Zhou; Tao Feng
Journal:  Sci Rep       Date:  2018-09-27       Impact factor: 4.379

5.  Oro-Pharyngeal Dysphagia in Parkinson's Disease and Related Movement Disorders.

Authors:  Miseon Kwon; Jae-Hong Lee
Journal:  J Mov Disord       Date:  2019-09-30

6.  Impact of simultaneous subthalamic and nigral stimulation on dysphagia in Parkinson's disease.

Authors:  Christina Pflug; Julie C Nienstedt; Alessandro Gulberti; Frank Müller; Eik Vettorazzi; Jana-Christiane Koseki; Almut Niessen; Till Flügel; Ute Hidding; Carsten Buhmann; Daniel Weiss; Christian Gerloff; Wolfgang Hamel; Christian K E Moll; Monika Pötter-Nerger
Journal:  Ann Clin Transl Neurol       Date:  2020-04-08       Impact factor: 4.511

Review 7.  Cueing Paradigms to Improve Gait and Posture in Parkinson's Disease: A Narrative Review.

Authors:  Niveditha Muthukrishnan; James J Abbas; Holly A Shill; Narayanan Krishnamurthi
Journal:  Sensors (Basel)       Date:  2019-12-11       Impact factor: 3.576

8.  Dopamine and Striatal Neuron Firing Respond to Frequency-Dependent DBS Detected by Microelectrode Arrays in the Rat Model of Parkinson's Disease.

Authors:  Guihua Xiao; Yilin Song; Yu Zhang; Yu Xing; Shengwei Xu; Mixia Wang; Junbo Wang; Deyong Chen; Jian Chen; Xinxia Cai
Journal:  Biosensors (Basel)       Date:  2020-09-28

9.  Entraining Stepping Movements of Parkinson's Patients to Alternating Subthalamic Nucleus Deep Brain Stimulation.

Authors:  Petra Fischer; Shenghong He; Alexis de Roquemaurel; Harith Akram; Thomas Foltynie; Patricia Limousin; Ludvic Zrinzo; Jonathan Hyam; Hayriye Cagnan; Peter Brown; Huiling Tan
Journal:  J Neurosci       Date:  2020-10-21       Impact factor: 6.167

Review 10.  Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Authors:  Brent Bluett; Alexander Y Pantelyat; Irene Litvan; Farwa Ali; Diana Apetauerova; Danny Bega; Lisa Bloom; James Bower; Adam L Boxer; Marian L Dale; Rohit Dhall; Antoine Duquette; Hubert H Fernandez; Jori E Fleisher; Murray Grossman; Michael Howell; Diana R Kerwin; Julie Leegwater-Kim; Christiane Lepage; Peter Alexander Ljubenkov; Martina Mancini; Nikolaus R McFarland; Paolo Moretti; Erica Myrick; Pritika Patel; Laura S Plummer; Federico Rodriguez-Porcel; Julio Rojas; Christos Sidiropoulos; Miriam Sklerov; Leonard L Sokol; Paul J Tuite; Lawren VandeVrede; Jennifer Wilhelm; Anne-Marie A Wills; Tao Xie; Lawrence I Golbe
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.